Advancing Next-Generation Medicine:
Integrated Flexible and Modular GMP Facility
Our facility is designed to international standards for the production of mRNA, CAR-T, MSCs, Biopharmaceuticals, and Viral Vectors.
Engineered for rapid scaling and seamless transitions between diverse product lines.
100% Single-Use technology combined with unidirectional flows (personnel/material) to eliminate cross-contamination risks.
Dedicated climate control for each suite, enabling multiple processes to run simultaneously without interference.
Risk Prediction
Early-stage validation and risk modeling to maximize operational efficiency and reliability.
Optimized air supply and return design to ensure absolute sterility and zero-dead-zone cleanroom environments.
mRNA
20L Bioreactor, provide 13 million dose vaccine annually
480 CAR-T; 68 batch MSC production
200L Bioreactor currently, 2x 200L 2027 coming soon
200L Bioreactor currently, 2x 2,000L 2027 coming soon
